alphatv

Σ2 – ΕΠΕΙΣΟΔΙΟ 84

Η Χλόη και ο πατήρ Νικόλαος επιστρέφουν από την Αθήνα χωρίς να δουν τη Σοφία, αλλά με τη διαβεβαίωση του Ηλία πως βρίσκεται υπό αυστηρή ...
alphatv

Σ2 – ΕΠΕΙΣΟΔΙΟ 88

Η οικογένεια Παυλίδη είναι σοκαρισμένη με τη σχέση Ελένης - Άννας. Ο Στέφανος βγαίνει εκτός εαυτού και αντιδρά ακραία. Η Άννα κινδυνεύει ...
antenna

GRAND HOTEL – 2ος ΚΥΚΛΟΣ – ΕΠΕΙΣΟΔΙΟ 104

GRAND HOTEL – 2ος ΚΥΚΛΟΣ – ΕΠΕΙΣΟΔΙΟ 100 Ανέβηκε στις 07/04/2026 22:38 Σχετικά Τελευταία ...
IEEE

Studying Factors Affecting Human β Defensin Type 3 Crossing Model Bacterial Lipid Membranes

Abstract: Human β defensin type 3 (hBD-3) is a cysteine-rich positively charged antimicrobial peptide (AMP), which is originally secreted from the human innate immune system. It has 45 residues, with ...
C&EN

Formal [3 + 2] Annulation of β,β-Disubstituted Enesulfinamides with Vinyl Thianthrenium Salt: Asymmetric Construction of 3,3-Disubstituted 1-Pyrrolines

The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.orglett.5c02008.
PNAS

Protein kinase A signaling regulates immune evasion by shaving and concealing fungal β-1,3-glucan

Pathogenic fungi impose a heavy burden upon human health. Many, particularly opportunistic fungal pathogens such as Candida albicans, have evolved strategies to evade our immune defenses. These ...
The Lancet

Long-term efficacy and safety of luspatercept for the treatment of anaemia in patients with transfusion-dependent β-thalassaemia (BELIEVE): final results from a phase 3 ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
C&EN

Regioselective [3 + 2] Annulation of β,γ-Alkynyl-α-ketimino Esters with 1,3-Dicarbonyls: The Synthesis of Highly Functionalized Dihydrofurans

Key Laboratory of Chemistry and Engineering of Forest Products, State Ethnic Affairs Commission, Guangxi Key Laboratory of Chemistry and Engineering of Forest Products, Guangxi Collaborative ...
ascopubs.org

A first-in-human, phase 1/2 trial of FOG-001, a β-catenin:TCF antagonist, in patients with locally advanced or metastatic solid tumors.

First-in-human, phase 1/2 study of GSK4524101, an oral DNApolymerase theta inhibitor (POLQi), alone or combined with the poly(ADP-ribose) polymerase (PARP) inhibitor (PARPi) niraparib in adults with ...